Targeting Lipocalin-2 in Inflammatory Breast Cancer Cells with Small Interference RNA and Small Molecule Inhibitors

Inflammatory Breast Cancer (IBC) is an aggressive form of invasive breast cancer, highly metastatic, representing 2–4% of all breast cancer cases in the United States. Despite its rare nature, IBC is responsible for 7–10% of all breast cancer deaths, with a 5-year survival rate of 40%. Thus, targete...

Descripción completa

Detalles Bibliográficos
Autores principales: Santiago-Sánchez, Ginette S., Noriega-Rivera, Ricardo, Hernández-O’Farrill, Eliud, Valiyeva, Fatma, Quiñones-Diaz, Blanca, Villodre, Emilly S., Debeb, Bisrat G., Rosado-Albacarys, Andrea, Vivas-Mejía, Pablo E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395282/
https://www.ncbi.nlm.nih.gov/pubmed/34445288
http://dx.doi.org/10.3390/ijms22168581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395282/
https://www.ncbi.nlm.nih.gov/pubmed/34445288
http://dx.doi.org/10.3390/ijms22168581

Ejemplares similares